MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1705339 CAUSEWAY BAY, K3

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$26,908,001

-$4,944,160 QoQ

Shares Held

81,325

+1.5% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,370,693 across 239 Biotechnology names. ALNY ranks #3 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	171,925	$76,771,388
2	REGN	Regeneron Pharmaceuticals, Inc.	69,854	$53,971,993
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	81,325	$26,908,001
4	INSM	INSMED Inc	122,958	$20,106,091
5	RPRX	Royalty Pharma plc	419,129	$20,105,617
6	PRAX	Praxis Precision Medicines, Inc.	27,744	$8,938,838
7	ARWR	Arrowhead Pharmaceuticals, Inc.	139,598	$8,752,793
8	MRNA	Moderna, Inc.	147,589	$7,497,520

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$26,908,001	81,325	+1.5%	Shares	Defined	2026-05-15
2025-12-31	$31,852,161	80,101	+650.6%	Shares	Defined	2026-02-17
2025-09-30	$4,865,976	10,671	-7.7%	Shares	Defined	2025-11-14
2025-06-30	$3,768,946	11,558	-17.2%	Shares	Defined	2025-08-14
2025-03-31	$3,767,587	13,953	-5.3%	Shares	Defined	2025-05-15
2024-12-31	$3,466,349	14,731	-42.9%	Shares	Defined	2025-02-14
2024-09-30	$7,099,073	25,812	-17.5%	Shares	Defined	2024-11-14
2024-06-30	$7,604,199	31,293	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.